← Back to Search

Neuromuscular Training for ACL Injury

N/A
Waitlist Available
Led By Gregory D Myer, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-training testing), week 6 (post-training testing)
Awards & highlights

Study Summary

This trial will study how well a new type of training that uses brain feedback helps people's muscles get stronger.

Eligible Conditions
  • Anterior Cruciate Ligament (ACL) Injury
  • Anterior Cruciate Ligament Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-training testing), week 6 (post-training testing)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-training testing), week 6 (post-training testing) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diffusion Tensor Imaging
Secondary outcome measures
Change in TBSS measured change in fMRI regions of interest

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: aNMT BiofeedbackExperimental Treatment1 Intervention
Participants randomized to receive a neuromuscular training intervention that incorporates biofeedback training.
Group II: Sham BiofeedbackPlacebo Group1 Intervention
Participants randomized to receive a neuromuscular training intervention with sham feedback training.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,626 Previous Clinical Trials
2,560,614 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiLead Sponsor
813 Previous Clinical Trials
6,531,449 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
483 Previous Clinical Trials
1,086,853 Total Patients Enrolled
5 Trials studying Anterior Cruciate Ligament Injury
1,424 Patients Enrolled for Anterior Cruciate Ligament Injury

Media Library

aNMT Biofeedback Clinical Trial Eligibility Overview. Trial Name: NCT04069520 — N/A
Anterior Cruciate Ligament Injury Research Study Groups: aNMT Biofeedback, Sham Biofeedback
Anterior Cruciate Ligament Injury Clinical Trial 2023: aNMT Biofeedback Highlights & Side Effects. Trial Name: NCT04069520 — N/A
aNMT Biofeedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT04069520 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently recruiting participants?

"According to clinicaltrials.gov, this medical trial is still in need of participants and has been since June 1st 2019. It was last updated on October 24th 2022."

Answered by AI

What is the current enrolment rate for this clinical trial?

"Affirmative. Clinicaltrials.gov hosts evidence that indicates this clinical trial, which was established on June 1st 2019, is actively recruiting for participants. Two medical centres are looking to enrol 120 patients in total."

Answered by AI

May individuals aged 75 and younger partake in this medical experiment?

"Individuals aged from 12 to 19 are eligible for participation in this research project."

Answered by AI

Is it possible for me to join this research endeavor?

"This research trial requires 120 minors aged 12 to 19 with anterior cruciate ligament injury who have enrolled in the parent study "Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality" as a primary criteria."

Answered by AI

Who else is applying?

What site did they apply to?
Cincinanti Childrens Hospital Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I'm a great test subject that needs money.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

What is the process like?
PatientReceived 2+ prior treatments
~16 spots leftby Mar 2025